logo

For the Inventor, By the Inventor

Princeton, NJ, United States of America

The Liposome Company, Inc.


USPTO Granted Patents = 115


Forward Citations = 5,303

Loading Chart...
Loading Chart...

89 inventors (with patents filed for the assignee):

goldMedal Andrew S Janoff (66 out of 80 patents)

silverMedal Pieter Rutter Cullis (25 out of 72 patents)

bronzeMedal Alan L Weiner (24 out of 26 patents)

4.  Eric G Mayhew (20 out of 24 patents)

5.  Mircea C Popescu (20 out of 24 patents)

6.  Marcel B Bally (17 out of 48 patents)

7.  Paul A Tremblay (16 out of 18 patents)

8.  Robert P Lenk (13 out of 16 patents)

9.  Imran Ahmad (12 out of 32 patents)

10.  J Craig Franklin (12 out of 13 patents)

11.  Suresh K Bhatia (12 out of 12 patents)

12.  Michael W Fountain (12 out of 13 patents)

13.  Michael J Hope (11 out of 40 patents)

14.  Lois E Bolcsak (11 out of 11 patents)

15.  Sharma R Minchey (10 out of 10 patents)


Core Competencies:
Liposomal Drug Delivery
Hydrophobic Taxane Derivatives
Etherlipid Liposomes
Peptide-Lipid Conjugates
Liposomal Antineoplastic Agents
Interdigitation-Fusion Liposomes
Pharmaceutical Compositions
Immune Response Potentiation
Low Toxicity Drug-Lipid Complexes
Diagnostic Assays
Multilamellar Liposomes
Arachidonic Acid Metabolites

115 patents:

1. RE39042 - Etherlipid-containing multiple lipid liposomes (2006-03-27),
2. 6500461 - Particulate formulations (2002-12-31),
3. 6482850 - Hydrolysis-promoting hydrophobic taxane derivatives (2002-11-19),
4. 6406713 - Methods of preparing low-toxicity drug-lipid complexes (2002-06-18),
5. 6392063 - Hydrolysis-promoting hydrophobic taxane derivatives (2002-05-21),
6. 6352716 - Steroidal liposomes (2002-03-05),
7. 6294191 - N-acyl phosphatidylethanolamine-mediated liposomal drug delivery (2001-09-25),
8. 6291690 - Hydrophobic taxane derivatives (2001-09-18),
9. 6261792 - Lipid-dependent diagnostic assays (2001-07-17),
10. 6180137 - Etherlipid-containing multiple lipid liposomes (2001-01-30),
11. 6153736 - Modified ether glyceroglycolipids (2000-11-28),
12. 6143716 - Liposomal peptide-lipid conjugates and delivery using same (2000-11-07),
13. 6120797 - N-acyl phosphatidylethanolamine-mediated liposomal drug delivery (2000-09-19),
14. 6118011 - Preparation of liposomal taxanes (2000-09-12),
15. 6107332 - Hydrolysis-promoting hydrophobic taxane derivatives (2000-08-22),
The Liposome Company, Inc. is a biopharmaceutical company that specializes in the development, production, and commercialization of liposomal drugs. With over two decades of experience, we have established ourselves as a leader in the field of liposome technology. We focus on creating innovative drug delivery systems using liposomes, which are small vesicles made up of lipids. Our liposomal drugs provide improved efficacy, reduced side effects, and targeted delivery for various diseases including cancer, infectious diseases, and genetic disorders.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

115 Patents

#18 in Princeton, NJ

#152 in New Jersey

#3,211 in US

#6,695 in the World

...
Princeton, NJ, United States of America

The Liposome Company, Inc.

Forward Citations = 5,303

89 inventors:

goldMedal Andrew S Janoff (66 out of 80 patents)

silverMedal Pieter Rutter Cullis (25 out of 72 patents)

bronzeMedal Alan L Weiner (24 out of 26 patents)

4.  Eric G Mayhew (20 out of 24 patents)

5.  Mircea C Popescu (20 out of 24 patents)

Please report any incorrect information to support@idiyas.com
Loading…